Michael F Bimson

Agilent Technologies (United Kingdom)

Papers

1

Total Citations

45

H-Index

1

About

Michael F. Bimson is a leading figure in the development of high-throughput genomic technologies, with his most-cited work centering on the automation of chromatin immunoprecipitation sequencing (ChIP-seq). His major contribution, the AHT-ChIP-seq protocol, revolutionized the field by transforming a labor-intensive, manual method into a completely automated, robotic system for identifying genome-wide DNA-protein interactions. This innovation, detailed in his highly cited 2013 paper (45 citations), dramatically increased the throughput and reproducibility of ChIP-seq experiments. To validate the protocol’s quality, Bimson successfully applied it to five different proteins in mouse livers, demonstrating its robustness and reliability. This work has had a lasting impact by enabling large-scale epigenetic studies that were previously impractical, paving the way for more comprehensive analyses of gene regulation. Bimson’s achievements are particularly notable for bridging the gap between traditional molecular biology and modern automation, making him a key contributor to the advancement of functional genomics.

Research Focus

Key Achievements

1
H-Index
1
Papers
45
Total Citations
45
Avg Citations/Paper
🏆 Most Cited Paper
AHT-ChIP-seq: a completely automated robotic protocol for high-throughput chromatin immunoprecipitation
45 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Agilent Technologies (United Kingdom)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago